Overview

A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate of the safety and efficacy of decitabine treatment of Myelodysplastic Syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Cttq
Treatments:
Azacitidine
Decitabine